Financing ·
MeiraGTx Holdings plc entered into a Royalty Note Purchase Agreement for up to $375 million in senior secured royalty…
MGTXMeiraGTx Holdings plc
MeiraGTx Holdings plc entered into a Royalty Note Purchase Agreement for up to $375 million in senior secured royalty notes, with an initial $100 million purchase on June 30, 2026, and a second $25 million purchase scheduled for July 17, 2026. The agreement includes options for additional purchases based on clinical data or regulatory approvals. Additionally, the company entered into a securities purchase agreement with TPC Investments for $10.0 million via the issuance of 950,570 ordinary shares at $10.52 per share. MeiraGTx is a biotechnology company focused on gene therapy development.